Biopol Chemicals opened at ₹51.00, in line with its previous close of ₹51.00. During today's session, the stock has traded between ₹48.50 and ₹51.00, with an average traded price of ₹49.71. It is currently showing a downward intraday trend.
return calculator
Time Period
An investment of ₹10,000 made 1 year ago in Biopol Chemicals is now worth
₹ 4,597.00
resulting in a loss of
₹ 5,403.00 (54.03%)
invest now
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
-2.50 (-4.90%)
Day High
₹51.00
Day Low
₹48.50
Day Open
₹51.00
Prev Close
₹51.00
Volume
15,600
Value Traded
₹0.08 Cr
1W Return
-1.62%
1M Return
1.68%
3M Return
-47.40%
6M Return
-53.70%
1Y Return
-54.03%
Fundamentals
Market Cap (₹ Cr.)
52
PE Ratio
-
PB Ratio
1.10
Dividend Yield
-
ROE
17.98%
ROCE
24.67%
Book Value (₹)
46.20
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
Investment Returns
1 Week
-1.62%
6 Week
-
1 Month
1.68%
3 Month
-47.40%
9 Month
-54.03%
Financials
Yearly
All values in ₹ crores
No data available.
Share Holding Pattern
Promoter65.81%
FII4.70%
DII0.54%
Retails & Others17.41%
Updates
12Jun
Biopol Chemicals appoints Vandan Vij Sarkar and Sukhomoy Das as Directors
Biopol Chemicals Limited appointed Ms. Vandan Vij Sarkar as a Non-Executive Director and Mr. Sukhomoy Das as a Non-Executive Independent Director to its Board effective June 11, 2026. Ms. Sarkar brings over 25 years of experience in the chemicals industry, while Mr. Das contributes over 30 years of expertise in healthcare and governance. The Board also reconstituted its Audit and Nomination and Remuneration Committees to comply with regulatory requirements.
4mo ago
1May
Biopol Chemicals Limited Reports Strong Financial Performance for FY26
Biopol Chemicals Limited reported exceptional financial performance for FY26 with revenue from operations growing 64.87% to ₹8,114.33 lakhs and net profit surging 108.12% to ₹897.41 lakhs. The Board approved these audited results on April 30, 2026, with statutory auditors providing an unmodified opinion. The company's balance sheet strengthened significantly with total assets reaching ₹6,977.53 lakhs.
